Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pulmonary artery aneurysm induced by lung abscess.
Hayakawa Y, Yamasaki K, Funada M, Komatsu M, Maeda Y, Yatera K. Hayakawa Y, et al. Among authors: funada m. Respirol Case Rep. 2023 Sep 5;11(10):e01213. doi: 10.1002/rcr2.1213. eCollection 2023 Oct. Respirol Case Rep. 2023. PMID: 37681069 Free PMC article.
Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial.
Takazono T, Hosogaya N, Fukushima K, Morio R, Irifune S, Miyamura T, Harada Y, Nagayoshi Y, Kondo A, Mihara T, Fukuda Y, Sasaki E, Sawai T, Imamura Y, Morikawa T, Futsuki Y, Inoue Y, Fukushima K, Suyama N, Tanaka H, Hanaka T, Shimabukuro I, Hata R, Ota K, Morimoto S, Nakada N, Ito Y, Yoshida M, Takeda K, Ide S, Iwanaga N, Nemoto K, Funada M, Izumikawa K, Yatera K, Yanagihara K, Mukae H. Takazono T, et al. Among authors: funada m. J Infect Chemother. 2024 Jul;30(7):597-602. doi: 10.1016/j.jiac.2024.01.003. Epub 2024 Jan 6. J Infect Chemother. 2024. PMID: 38190963 Free article. Clinical Trial.
Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Sakai H, Miyazaki Y, Nakayamada S, Kubo S, Hanami K, Fukuyo S, Yamaguchi A, Miyagawa I, Ueno M, Tanaka H, Todoroki Y, Ohkubo N, Funada M, Matsunaga S, Tanaka Y. Sakai H, et al. Among authors: funada m. Rheumatology (Oxford). 2024 Sep 17:keae495. doi: 10.1093/rheumatology/keae495. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39288317
Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
Ohkubo N, Miyazaki Y, Nakayamada S, Fukuyo S, Inoue Y, Satoh-Kanda Y, Tanaka H, Todoroki Y, Miyata H, Nagayasu A, Funada M, Kobayashi H, Sakai H, Kosaka S, Matsunaga S, Tomoyose Y, Nohara H, Tanaka Y. Ohkubo N, et al. Among authors: funada m. Rheumatol Ther. 2024 Oct;11(5):1303-1319. doi: 10.1007/s40744-024-00707-9. Epub 2024 Aug 9. Rheumatol Ther. 2024. PMID: 39120846 Free PMC article.
Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation.
Arita H, Tanaka R, Kikukawa S, Tomizawa T, Sakata H, Funada M, Tomiyama K, Hashimoto M, Tasaka T, Tabata H, Nakamura K, Makino K, Oshitari T, Natsugari H, Takahashi H. Arita H, et al. Among authors: funada m. J Med Chem. 2024 Jun 27;67(12):10447-10463. doi: 10.1021/acs.jmedchem.4c00935. Epub 2024 Jun 13. J Med Chem. 2024. PMID: 38869493 Free PMC article.
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto K, Nakayamada S, Fujino Y, Miyata H, Kubo S, Fujita Y, Inoue Y, Matsunaga S, Iwata S, Hanami K, Todoroki Y, Yoshinari-Korekoda H, Kawabe A, Yamaguchi A, Ueno M, Satoh-Kanda Y, Kanda R, Funada M, Ohkubo N, Kusaka K, Kosaka S, Nagayasu A, Fukuyo S, Nawata M, Miyazaki Y, Tokunaga M, Tanaka K, Okada Y, Tanaka Y. Sonomoto K, et al. Among authors: funada m. Rheumatology (Oxford). 2024 Aug 1;63(8):2239-2248. doi: 10.1093/rheumatology/kead579. Rheumatology (Oxford). 2024. PMID: 37934120
115 results